comprehensive -WSS

comprehensive

author：entertainment 2025-09-28 20:32:19 - browse：95

Becton Dickinson plans to pay $4.2 billion for Edwards Lifesciences’ critical care business, which sells technology that monitors the heart conditions of critically ill patients.

Edwards had told investors in December 2023 that it planned to spin off the business in order to focus more sharply on addressing structural defects in the heart. BD, meanwhile, wants to increase its monitoring presence in hospitals. In a statement announcing the acquisition, the company touted the “advanced AI algorithms” used in Edwards’ monitors.

BD CEO Tom Polen said in a statement that the acquisition will bolster BD’s portfolio of “AI-enabled clinical decision tools” and digital health products in general.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Heat wave can put hearts into ‘oxygen debt,' lab experiment shows

WSS

Lilly's Alzheimer's drug donanemab backed by FDA advisers

Stanford president to resign after investigation of research

Plane’s emergency slide plummets from sky, hits Chicago home

Ebola public health emergency is over, WHO declares

Statins may not be needed by millions of people, study suggests

'Essentially witchcraft:' A former naturopath takes on the field

hotspot

comprehensive

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

knowledge

Duchenne breakthrough therapy leaves behind pioneering families

Stanford updates investigation of president’s past research

FDA approval of Sarepta Duchenne genetic therapy gives me hope

STAT's 2023 biotech VC rankings: ARCH Venture Partners tops list

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Medical device trials still don't enroll enough women, study finds

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Curing rare childhood diseases will falter unless Congress steps up

Sports medicine is finally prioritizing gender equality

Why the Crimean Bridge is key to Russia's war in Ukraine

knowledge

India sets sights on home

The system is set up to fail children with medical complexity

Stephen Quake on the Chan Zuckerberg quest to conquer disease

'Reaching a detente': STAT's Helen Branswell on covering Covid

How faith leaders like me can help address America's obesity epidemic

Actors' union, Hollywood studios squabble over which side to blame as strike enters 5th day

knowledge

hotspot

Wikipedia

leisure time